Novo Nordisk

Novo Nordisk

Produktion af lægemidler

Driving change to defeat serious chronic diseases, built upon our heritage in diabetes.

Om os

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Websted
https://www.novonordisk.com
Branche
Produktion af lægemidler
Virksomhedsstørrelse
Over 10.001 medarbejdere
Hovedkvarter
Bagsværd
Type
Aktieselskab
Grundlagt
1923
Specialer
Pharmaceuticals, Insulin, obesity, Rare Diseases og Diabetes

Beliggenheder

  • Primær

    Novo Alle

    Bagsværd, 2880, DK

    Se ruten
  • Hallas Alle 1

    Kalundborg, Zealand 4400, DK

    Se ruten
  • Thurgauerstrasse 36

    Zurich, ZH 8050, CH

    Se ruten
  • 45 Avenue d'Orleans

    Chartres, Center 28000, FR

    Se ruten
  • Novo Nordisk Park 1

    Malov, Capital Region 2760, DK

    Se ruten
  • ulica 17 Stycznia 45B

    Warsaw, MA 02-146, PL

    Se ruten
  • Vandtarnsvej 108

    Soborg, Capital Region 2860, DK

    Se ruten
  • 800 Scudders Mill Rd

    Plainsboro, NJ 08536, US

    Se ruten
  • Novo Alle 1

    Bagsvaerd, Capital Region 2880, DK

    Se ruten
  • 32

    Bengaluru, Karnataka 560066, IN

    Se ruten
  • Dubai Healthcare City

    Dubai, Dubai, AE

    Se ruten
  • Avenida Presidente Riesco 5335

    Las Condes, Santiago Metropolitan 7550000, CL

    Se ruten
  • Brennum Park 24A

    Hillerod, Capital Region 3400, DK

    Se ruten
  • Avenida Francisco Matarazzo, 1350

    Sao Paulo, SP 05001-100, BR

    Se ruten
  • 530 Fairview Ave N

    Seattle, Washington 98109, US

    Se ruten
  • 5225 Exploration Dr

    Indianapolis, Indiana 46241, US

    Se ruten
  • 6300 Dumbarton Circle

    Fremont, California 94555, US

    Se ruten
  • 255 Main St

    Cambridge, Massachusetts 02142, US

    Se ruten

Medarbejdere hos Novo Nordisk

Opdateringer

Tilsvarende sider

Aktie

NVO

NYSE

20 minutters forsinkelse

87,65 US$

0,28 (0,321 %)

Åbningspris
87,17
Lavpunkt
86,87
Højdepunkt
88,06

Data fra Refinitiv

Få flere oplysninger på Bing

Finansiering

Novo Nordisk 1 runde i alt

Seneste runde

Post IPO-egenkapital

22.000.000,00 US$

Læs mere på crunchbase